ALLMedicine™ Angina Pectoris Center
Research & Reviews 3,203 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789672
BMC Medical Imaging; Groepenhoff F, Klaassen RGM et. al.
Jan 7th, 2021 - Coronary microvascular dysfunction (CMD) is an important underlying cause of angina pectoris. Currently, no diagnostic tool is available to directly visualize the coronary microvasculature. Invasive microvascular reactivity testing is the diagnost...
https://doi.org/10.1007/s00380-020-01756-0
Heart and Vessels; Nishida T, Hiro T et. al.
Jan 6th, 2021 - The significance of microvessels within atherosclerotic plaques is not yet fully clarified. Associated with plaque vulnerability. The aim of this study is to examine tissue characteristics of plaque with microvessels detected by optical coherence ...
https://doi.org/10.1002/clc.23516
Clinical Cardiology REFERENCES; Wu E, Mårtensson J et. al.
Jan 5th, 2021 - Enhanced external counterpulsation (EECP) is a noninvasive treatment that can decrease limiting symptoms in patients with refractory angina pectoris (RAP). Identifying responders to EECP is important as EECP is not widely available and relatively ...
https://doi.org/10.1007/s00296-020-04754-7 10.1093/eurheartj/ehx628 10.1161/CIR.0000000000000659 10.1093/eurheartj/ehw106 10.1161/CIR.0000000000000678 10.1186/s12916-019-1340-7 10.1016/S0140-6736(13)61752-3 10.1038/s41569-019-0202-5 10.1016/S2214-109X(19)30365-1 10.1161/01.cir.97.18.1837 10.23880/OAJC-16000124 10.1111/j.1541-9215.2007.06350.x 10.1136/annrheumdis-2014-206879 10.1016/j.amjcard.2012.03.044 10.3899/jrheum.190261 10.1136/annrheumdis-2016-209775 10.1007/s00296-016-3619-8 10.1007/s00296-018-4053-x 10.1038/nrrheum.2015.112 10.1136/annrheumdis-2013-204531 10.1136/annrheumdis-2014-206411 10.1371/journal.pone.0205506 10.1186/s13075-020-02178-z 10.1093/rheumatology/kex038 10.1002/art.1780400928 10.1136/ard.2010.138461 10.1136/ard.2010.133645 10.1136/ard.38.5.434 10.2307/2529990 10.1136/annrheumdis-2014-205675 10.1136/annrheumdis-2016-210973 10.1093/rheumatology/kew475 10.1016/j.reuma.2017.06.002 10.1093/oxfordjournals.aje.a009122 10.3899/jrheum.180726 10.1136/ard.2008.094151 10.1007/s00296-020-04691-5 10.1002/acr.23875 10.1016/S0140-6736(18)30664-0 10.1136/rmdopen-2015-000166 10.1023/B:EJEP.0000036568.02655.f8
Rheumatology International; Da Silva Domingues V, Rodrigues AM et. al.
Jan 3rd, 2021 - Cardiovascular diseases represent the first cause of death globally. Inflammatory rheumatic disease (IRMD) patients, due to their lifelong inflammatory status, are at increased risk of developing premature cardiovascular disease. We aimed to asses...
https://doi.org/10.1016/j.amjcard.2020.12.065
The American Journal of Cardiology; Martínez-Sánchez C, Azar-Manzur F et. al.
Jan 1st, 2021 - Extracorporeal shockwave myocardial revascularization (ESMR) is a therapy for refractory angina pectoris. Our aim was to assess the efficacy and safety of ESMR in the management of patients with stable coronary artery disease (CAD) and heart failu...
Guidelines 5 results
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;
Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al
Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723022
The Canadian Journal of Cardiology; McGillion M, L'Allier PL et. al.
Jul 8th, 2009 - Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.|2009|McGillion M,L'Allier PL,Arthur H,Watt-Watson J,Svorkdal N,|epidemiology,therapy,epidemiology,
https://www.sciencedirect.com/science/article/pii/S0735109707018232
Journal of the American College of Cardiology;
Dec 11th, 2006 - The importance of resting heart rate (HR) as a prognostic factor and potential therapeutic target is not yet generally accepted. Recent large epidemiologic studies have confirmed earlier studies that showed resting HR to be an independent predicto...
https://www.kapspargosprinklerx.com
Kapspargo Sprinkle™ extended-release capsules are for the treatment of hypertension, angina pectoris, and heart failure. Learn more here.
Drugs 1,249 results see all →
Clinicaltrials.gov 4,495 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0241448-5727-4c68-ae2a-6f41cd962d7c
Jan 13th, 2021 - Propranolol Hydrochloride Extended-Release Capsules, USP, are indicated in the management of hypertension. They may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochlorid...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89178e8c-2bf4-811b-e053-2995a90a6070
Jan 13th, 2021 - Metoprolol tartrate tablets, USP are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Metoprolol tartrate tablets, USP are indicated in the long-term treatment of angina pect...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac7fdd46-a27b-411d-9916-5a5f3bd72f1c
Jan 13th, 2021 - Isosorbide Dinitrate Tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in abo...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b51722e-6ed8-4a90-9725-5e5927bb261c
Jan 12th, 2021 - Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol tartrate tablets are indicated in the long-term treat...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8cf19ff-65fa-7044-e053-2a95a90a7a30
Jan 12th, 2021 - Metoprolol succinate, is a beta 1-selective adrenoceptor blocking agent. Metoprolol succinate extended-release tablets, USP are indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fata...
News 73 results
https://www.staging.medscape.com/viewarticle/939965
Oct 27th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...
https://www.medscape.com/viewarticle/939965
Oct 27th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;
Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...
https://www.medscape.com/viewarticle/914656
Jun 18th, 2019 - After a diagnosis of myocardial infarction (MI) or angina pectoris, individuals enrolled in the English Longitudinal Study of Aging (ELSA) showed more accelerated cognitive decline than those who remained free of coronary heart disease (CHD). The ...
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al
Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...
